Safety, Tolerability, and Pharmacokinetics of Zagotenemab in Participants with Symptomatic Alzheimer's Disease: A Phase I Clinical Trial. - Willis BA; Lo AC; Dage JL; Shcherbinin S; Chinchen L; Andersen SW; LaBell ES; Perahia DGS; Hauck PM; Lowe SL (Journal of Alzheimer's disease reports, 2023)